Literature DB >> 8288897

Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system.

P D Crowe1, T L VanArsdale, B N Walter, K M Dahms, C F Ware.   

Abstract

Human LT alpha and a fusion protein (p60:Fc) comprised of the extracellular domain of the 60 kDa TNF receptor (TNFR60) fused to the Fc portion of human IgG1 were produced in insect cells infected with recombinant baculoviruses. The p60:Fc fusion produced in insect cells accumulates in culture supernatants to levels > 2 mg/l. Purified p60:Fc binds human TNF and LT alpha with high affinity (200-600 pM) and neutralizes TNF cytolytic activity at equimolar stoichiometric concentration. The data show that p60:Fc is an effective ligand-precipitating reagent which recognizes recombinant LT alpha produced in mammalian or insect cells and naturally occurring LT alpha produced in T cells. The levels of human LT alpha produced in baculovirus-infected insect cells is estimated to be approximately 20 mg/l. Insect cell-derived human LT alpha is biologically active in an L929 cytotoxicity assay and is efficiently neutralized by p60:Fc. These data demonstrate that the baculovirus system is useful for overexpressing biologically active LT alpha and p60:Fc and therefore, may be applicable to other oligomeric cytokines and soluble dimeric cytokine receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288897     DOI: 10.1016/0022-1759(94)90212-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Soluble FasR ligand-binding domain: high-yield production of active fusion and non-fusion recombinant proteins using the baculovirus/insect cell system.

Authors:  J Mahiou; J P Abastado; L Cabanie; F Godeau
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  Inhibition of herpes simplex virus gD and lymphotoxin-alpha binding to HveA by peptide antagonists.

Authors:  M R Sarrias; J C Whitbeck; I Rooney; L Spruce; B K Kay; R I Montgomery; P G Spear; C F Ware; R J Eisenberg; G H Cohen; J D Lambris
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Suppression by apoptotic cells defines tumor necrosis factor-mediated induction of glomerular mesangial cell apoptosis by activated macrophages.

Authors:  J S Duffield; C F Ware; B Ryffel; J Savill
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

4.  A third distinct tumor necrosis factor receptor of orthopoxviruses.

Authors:  V N Loparev; J M Parsons; J C Knight; J F Panus; C A Ray; R M Buller; D J Pickup; J J Esposito
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

5.  Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32).

Authors:  M Bitzer; F Prinz; M Bauer; M Spiegel; W J Neubert; M Gregor; K Schulze-Osthoff; U Lauer
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Prions and lymphoid organs: solved and remaining mysteries.

Authors:  Tracy O'Connor; Adriano Aguzzi
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

7.  Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes.

Authors:  Tracy O'Connor; Nathalie Frei; Jana Sponarova; Petra Schwarz; Mathias Heikenwalder; Adriano Aguzzi
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

8.  Fas and Fas ligand interactions suppress melanoma lung metastasis.

Authors:  L B Owen-Schaub; K L van Golen; L L Hill; J E Price
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

9.  Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines.

Authors:  J L Browning; K Miatkowski; I Sizing; D Griffiths; M Zafari; C D Benjamin; W Meier; F Mackay
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids.

Authors:  Y Yang; M Merćep; C F Ware; J D Ashwell
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.